EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSOPRG00000016134
Gene Symbol: DHCR24
1 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSOPRG00000003618
Gene Symbol: HMGCR
1 Cross references
270 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSOPRG00000016575
Gene Symbol: HPD
1 Cross references
204 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSOPRG00000004066
Gene Symbol: NT5E
1 Cross references
249 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSOPRG00000011474
Gene Symbol: HTR2A
1 Cross references
218 Possible Orthologues:

5-Hydroxytryptamine Receptor 2b

Ensembl ID : ENSOPRG00000007444
Gene Symbol: HTR2B
1 Cross references
204 Possible Orthologues:

5-Hydroxytryptamine Receptor 3d

Ensembl ID : ENSOPRG00000005498
Gene Symbol: HTR3D
1 Cross references
57 Possible Orthologues:

5-Hydroxytryptamine Receptor 4

Ensembl ID : ENSOPRG00000013465
Gene Symbol: HTR4
1 Cross references
200 Possible Orthologues:

5-Hydroxytryptamine Receptor 5a

Ensembl ID : ENSOPRG00000005160
Gene Symbol: HTR5A
3 Cross references
210 Possible Orthologues:

5-Hydroxytryptamine Receptor 6

Ensembl ID : ENSOPRG00000002947
Gene Symbol: HTR6
3 Cross references
114 Possible Orthologues:

60s Acidic Ribosomal Protein P1-Like

Ensembl ID : ENSOPRG00000001163
Gene Symbol: LOC101522416
2 Cross references
221 Possible Orthologues:

A-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSOPRG00000005380
Gene Symbol: ARAF
1 Cross references
191 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).